BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31285298)

  • 21. Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.
    Sexton R; Mahdi Z; Chaudhury R; Beydoun R; Aboukameel A; Khan HY; Baloglu E; Senapedis W; Landesman Y; Tesfaye A; Kim S; Philip PA; Azmi AS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
    Marullo R; Rutherford SC; Revuelta MV; Zamponi N; Culjkovic-Kraljacic B; Kotlov N; Di Siervi N; Lara-Garcia J; Allan JN; Ruan J; Furman RR; Chen Z; Shore TB; Phillips AA; Mayer S; Hsu J; van Besien K; Leonard JP; Borden KLB; Inghirami G; Martin P; Cerchietti L
    Cancer Res; 2024 Jan; 84(1):101-117. PubMed ID: 37801604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NEDD4 protects vascular endothelial cells against Angiotensin II-induced cell death via enhancement of XPO1-mediated nuclear export.
    Xu J; Sheng Z; Li F; Wang S; Yuan Y; Wang M; Yu Z
    Exp Cell Res; 2019 Oct; 383(1):111505. PubMed ID: 31326389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia.
    Vercruysse T; De Bie J; Neggers JE; Jacquemyn M; Vanstreels E; Schmid-Burgk JL; Hornung V; Baloglu E; Landesman Y; Senapedis W; Shacham S; Dagklis A; Cools J; Daelemans D
    Clin Cancer Res; 2017 May; 23(10):2528-2541. PubMed ID: 27780859
    [No Abstract]   [Full Text] [Related]  

  • 25. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
    Miloudi H; Leroy K; Jardin F; Sola B
    Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding XPO1 target networks using systems biology and mathematical modeling.
    Muqbil I; Kauffman M; Shacham S; Mohammad RM; Azmi AS
    Curr Pharm Des; 2014; 20(1):56-65. PubMed ID: 23530499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.
    Schmidt J; Braggio E; Kortuem KM; Egan JB; Zhu YX; Xin CS; Tiedemann RE; Palmer SE; Garbitt VM; McCauley D; Kauffman M; Shacham S; Chesi M; Bergsagel PL; Stewart AK
    Leukemia; 2013 Dec; 27(12):2357-65. PubMed ID: 23752175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization.
    Pinarbasi ES; Cağatay T; Fung HYJ; Li YC; Chook YM; Thomas PJ
    Sci Rep; 2018 May; 8(1):7083. PubMed ID: 29728608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes.
    Martin AP; Jacquemyn M; Lipecka J; Chhuon C; Aushev VN; Meunier B; Singh MK; Carpi N; Piel M; Codogno P; Hergovich A; Parrini MC; Zalcman G; Guerrera IC; Daelemans D; Camonis JH
    EMBO Rep; 2019 Nov; 20(11):e48150. PubMed ID: 31544310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
    Yoshimura M; Ishizawa J; Ruvolo V; Dilip A; Quintás-Cardama A; McDonnell TJ; Neelapu SS; Kwak LW; Shacham S; Kauffman M; Tabe Y; Yokoo M; Kimura S; Andreeff M; Kojima K
    Cancer Sci; 2014 Jul; 105(7):795-801. PubMed ID: 24766216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
    Caillot M; Miloudi H; Taly A; Profitós-Pelejà N; Santos JC; Ribeiro ML; Maitre E; Saule S; Roué G; Jardin F; Sola B
    Mol Oncol; 2023 Dec; 17(12):2546-2564. PubMed ID: 36727672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of a Trimeric Xpo1-Ran[GTP]-Ded1 Exportin Complex Modulates ATPase and Helicase Activities of Ded1.
    Hauk G; Bowman GD
    PLoS One; 2015; 10(6):e0131690. PubMed ID: 26120835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRM1-mediated nuclear export of proteins and drug resistance in cancer.
    Turner JG; Sullivan DM
    Curr Med Chem; 2008; 15(26):2648-55. PubMed ID: 18991627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma.
    Gandhi UH; Senapedis W; Baloglu E; Unger TJ; Chari A; Vogl D; Cornell RF
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):335-345. PubMed ID: 29610030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of nuclear export signal orientation in binding to exportin CRM1.
    Fung HY; Fu SC; Brautigam CA; Chook YM
    Elife; 2015 Sep; 4():. PubMed ID: 26349033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
    Haines JD; Herbin O; de la Hera B; Vidaurre OG; Moy GA; Sun Q; Fung HY; Albrecht S; Alexandropoulos K; McCauley D; Chook YM; Kuhlmann T; Kidd GJ; Shacham S; Casaccia P
    Nat Neurosci; 2015 Apr; 18(4):511-20. PubMed ID: 25706475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy.
    Newell S; van der Watt PJ; Leaner VD
    IUBMB Life; 2024 Jan; 76(1):4-25. PubMed ID: 37623925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
    Booth DS; Cheng Y; Frankel AD
    Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.
    Miyake T; Pradeep S; Wu SY; Rupaimoole R; Zand B; Wen Y; Gharpure KM; Nagaraja AS; Hu W; Cho MS; Dalton HJ; Previs RA; Taylor ML; Hisamatsu T; Kang Y; Liu T; Shacham S; McCauley D; Hawke DH; Wiktorowicz JE; Coleman RL; Sood AK
    Clin Cancer Res; 2015 Jul; 21(14):3286-97. PubMed ID: 25878333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.